analysis was performed on a Shimadzu-LC 8A Liquid Chromatograph instrument (C18 column, 10 mm diameter, 250 mm length) with UV detector monitoring at 254 nm. Nuclear magnetic resonance spectra were recorded on Bruker (AV-400) 400 MHz spectrometer in deuterated solvents. Infrared (IR) spectra of the solid compounds were recorded on Bruker IFS66 V/s spectrometer using KBr pellets. IR spectra of the compounds soluble in low-boiling solvents were recorded with the same instrument using NaCl crystal. High-resolution Mass Spectrometry was recorded on Agilent 6538 Q-TOF LC-MS system and Shimadzu LC-MS 2020 spectrometer.
Optical density was measured by TecanInfinitePro series M200 Microplate Reader. Fluorescence images were taken using a Zeiss 510 Meta confocal laser-scanning microscope. The images were prepared using LSM 5 Image examiner. The animal experiments were performed at Indian Institute of Science and JNCASR following the institute guidelines.
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Synthesis and details of characterization.
General procedure for synthesis of N-alkylaminomethylarene hydrochlorides (1a-7a) These compounds were prepared using the protocol published earlier. 1 Briefly, in a mixture of dry chloroform and methanol (10 ml), aromatic aldehydes (1.27 mmol) and alkyl amines (1.27 mmol) were stirred at room-temperature (under Nitrogen atmosphere) for 6 h. At the end of 6h, the solution was cooled to 0  C before adding sodium borohydride (2.3 mmol) was added. This was stirred at room temperature for 12h. Subsequently, the solvents were evaporated under reduced pressure (not to dryness) and diluted with diethyl ether. 2N NaOH (20 ml) was added to it and stirred for 15 minutes. The organic layer was then separated from the NaOH layer and was subsequently washed with water twice, brine and dried over MgSO 4 . The organic layer was then evaporated under reduced pressure to dryness before dissolving the residue in minimum volume of methanol. 4N HCl (3 ml) was added to it to obtain precipitates of the salt. The solvent was completely removed and the precipitate was dissolved in minimum volume of ethyl acetate (a few drops of methanol was added to dissolve completely). To this hexane was added to obtain pure crystals of the target compound (Yield: 70-90%). These crystals were filtered, dried and subsequently characterized using 1 H NMR, and Mass spectrometry. 
General procedure for amide coupling
Amide coupling was performed using a previously published scheme. 1 were added to it. The mixture was initially stirred at 0C for 30 minutes and then at RT for 24 h typically. At the end, organic layer was evaporated under reduced pressure before diluting to twice its original volume by addition of ethyl acetate. This ethylacetate layer was subsequently washed with 0.5 M KHSO 4 , H 2 O (thrice) and brine. After passage through anhydrous Na 2 SO 4 , the organic layer was evaporated under reduced pressure and the residue was purified using column S5 chromatography (5% MeOH/CHCl 3 ) to obtain the product in 65%-90% yield. The purified compound was subsequently characterized using 1 2 ,Lys (ε-NH-Boc)-α-NH-boc and α-CH of Lys(boc) 2 , 4H), 3.50-2.9 (δ-CH 2 of Lys(boc) 2 and Ar-CH 2 -N(-CH 2 -C 5 H 11 )Lys(boc) 2 , 4H), 
General procedure for deprotection of Boc groups (5-7)
The deprotection of Boc groups were performed using a previously published protocol. 1 Briefly, compounds (1b-7b) were dissolved in DCM and subsequently CF 3 COOH (50% by volume) was added and stirred at RT. The reactions were monitored by TLC until complete removal of starting material was observed. All the volatile components were removed, and the product was purified by reverse phase HPLC using 0.1% Trifluoroacetic acid (TFA) in water/acetonitrile (0-100%) as mobile phase to more than 95% purity. C 18 column (10mm diameter, 250 mm length) and UV detector (at 270 nm wavelength) were used. After drying the compounds in freeze drier, the compounds were characterized by 1 H NMR, 13 C NMR, IR and mass spectrometry. 
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Biological assays
Plasmodium falciparum culturing. Plasmodium falciparum 3D7 was cultured in human O+ erythrocytes in complete RPMI 1640 (Sigma Aldrich) medium supplemented with 0.5% albumax II (Invitrogen), 0.2% NaHCO3, 0.2% Glucose, 200μM Hypoxanthine and 5μg/L Gentamycin. At every 24 h, the spent medium was removed and replenished with fresh medium. The culture was scaled up by splitting it, once the parasitemia had increased up to 10%. A fresh O-positive human erythrocytes was added for the newer infection.
In vitro antimalarial activity
For in-vitro antimalarial screening, SYBR green I based fluorescence assay was used as reported by Smilkstein et al. with a minor modification. Parasites were synchronized to ring stages (haematocrit: 2%, parasitaemia: 1%, 100 μl) by sorbitol treatment. The compounds were serially diluted in complete RPMI media. Parasite cultures (50μL) were incubated with increasing concentrations of compounds in media (50μL) in a 96 well plate. The highest concentration tested was 10μM. CQ was used as positive controls and absence of compound was considered to be negative control. After 48 hr of incubation 100 μl of lysis buffer containing SYBR Green I was added to the 96 wells. The composition of the lysis buffer per mL is as follows: 0.2 μl of 10,000 X SYBR Green I (Sigma), Tris (20 mM; pH 7.5), EDTA (5 mM), saponin (0.008%; wt/vol), and Triton X-100 (0.08%; vol/vol). This solution (200μL) was then mixed gently with multi-channel pipette and incubated in dark at 37°C for 1 h. At the end of the incubation period, the solutions were transferred to black-round bottomed 96 well plates. Fluorescence was measured using a
Tecan plate reader with excitation and emission wavelengths centred at 485 and 530 nm respectively. The fluorescence intensities were plotted against increasing compound S16 concentrations and IC 50 (the 50% inhibitory concentration) was determined by analysis of sigmoidal curves. Giemsa-stained smears of compound-treated parasite cultures were also done in order to validate the results.
Haemolytic activity.
Hemolytic experiments were performed with slight modification of a previously reported protocol.
Erythrocytes were isolated from freshly drawn, heparinized human blood and re-suspended to 5 vol% in PBS (pH 7.4). In a 96-well microtiter plate, 150 μL of erythrocyte suspension was added to 50 μL of serially diluted compound. Two controls were made, one without compound and other with 50 μL of 1 vol% solution of Triton X-100. The plate was incubated for 1 h at 37°C. The plate was then centrifuged at 3,500 rpm for 5 min, 100 μL of the supernatant from each well was transferred to a fresh microtiter plate, and A 540 was measured. Percentage of hemolysis was determined as (A -A 0 )/(A total -A 0 ) x 100, where A is the absorbance of the test well, A 0 the absorbance of the negative controls (without compound), and A total the absorbance of 100% hemolysis wells (with Triton X-100), all at 540 nm. The HC 50 values and errors are reported as averages and standard errors of mean of at least two independent experiments (each experiment was performed in triplicates) respectively. The error of the experiments is less than 10%.
In vitro stage dependence of action
The stage dependence of action of the compounds were determined by addition of the compounds at specific stages of parasite development: ring, trophozoite and schizonts. To achieve a synchrony in stage development of P. falciparum, selective destruction of trophozoite and schizont stage erythrocytes by 5% sorbitol was used. 4 The parasites were tightly synchronized in the ring stages S17 using two rounds of sorbitol synchronization spaced 4h apart. This culture was divided into three groups. Each group was subdivided into two groups. In the subdivision, one served as treated while the other as positive control. The three groups were divided as rings, trophozoites and schizonts.
Compounds were added at concentrations twice their IC 50 values to the ring stage culture after second synchronization. In case of trophozoites the culture was allowed to grown for 24 hr before addition of compounds. In case of schizonts the compounds were allowed to grow for 38 hr before addition of compounds. Rings, trophozoites and schizonts were allowed to grow for 48h, 24h, and 12h respectively before Giemsa-stained smears from the assays were analyzed microscopically.
The ability of the compound to inhibit parasite development at different stages was gauged by comparing the numbers with untreated controls.
Mechanism of action (Microscopy)
For these experiments two dyes were used Rhodamine 123 and Lysotracker Green. Briefly, In a total volume of 200 μL, Parasite-infected erythrocytes (2% haematocrit and 3% parasitemia) were incubated at 37°C for 30 min with 1 µM rhodamine 123 (for parasite plasma membrane potential), or 10 nM LysoTracker Green (for DV potential) before incubation with the test compound for 4
hr. Untreated cultures served as negative controls. These were then transferred onto a cover slip, which was fixed using paraformaldehyde. The fixed coverslips were then visualized under a confocal microscope.
In-vivo toxicology
The in-vivo toxicology study was performed at JNCASR following the institute guidelines. For conducting in-vivo toxicology studies, the compounds (in PBS) were injected intravenously into female Balb/c mice (6-8 weeks old).
